Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Non-Current Assets (2021 - 2026)

Prokidney's (PROK) quarterly Non-Current Assets came in at $59.2 million in Q2 2026, up 24.23% year-over-year from $47.7 million in Q2 2025, and up 2.36% quarter-over-quarter from $57.9 million in Q1 2026.

Analysis

Prokidney (PROK) Non-Current Assets (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Non-Current Assets for 6 consecutive years, with $59.2 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 24.23% year-over-year to $59.2 million in Q2 2026; TTM through Jun 2026 was $223.6 million, a 21.65% increase from a year earlier, with the FY2025 full-year figure at $54.9 million, up 21.48% from the prior year.
  • Non-Current Assets was $59.2 million for Q2 2026 at Prokidney, up from $57.9 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $250.4 million in Q2 2022 and troughed at $13.1 million in Q3 2022.
  • A 5-year average of $64.2 million and a median of $47.0 million in 2023 frame the typical range for Non-Current Assets.
  • The widest YoY moves for Non-Current Assets: up 65845.09% in 2022, down 94.77% in 2022.
  • Over 5 years, Non-Current Assets stood at $13.3 million in 2022, then soared by 249.52% to $46.4 million in 2023, then dropped by 2.62% to $45.2 million in 2024, then climbed by 21.48% to $54.9 million in 2025, then gained by 7.93% to $59.2 million in 2026.
  • The last three Non-Current Assets figures came in at $59.2 million (Q2 2026), $57.9 million (Q1 2026), and $54.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 441.00 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 279.00 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 451.27 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 523.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 150.83 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 207.76 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 35.91 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 964.69 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 238.14 Mn
10 Prokidney 346.07 Mn 346.07 Mn - 59.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.25 Mn
Mar 31, 2026 57.88 Mn
Dec 31, 2025 54.90 Mn
Sep 30, 2025 51.62 Mn
Jun 30, 2025 47.69 Mn
Mar 31, 2025 46.40 Mn
Dec 31, 2024 45.19 Mn
Sep 30, 2024 44.57 Mn
Jun 30, 2024 48.90 Mn
Mar 31, 2024 47.61 Mn
Dec 31, 2023 46.41 Mn
Sep 30, 2023 45.38 Mn
Jun 30, 2023 17.79 Mn
Mar 31, 2023 15.01 Mn
Dec 31, 2022 13.28 Mn
Sep 30, 2022 13.07 Mn
Jun 30, 2022 250.37 Mn
Mar 31, 2022 250.16 Mn
Dec 31, 2021 13.03 Mn
Sep 30, 2021 250.00 Mn